Hudson Bay Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
VCM
VPM
Hudson Bay Capital Management's ABBV Position: Q1 2026 in Review
Hudson Bay Capital Management opened a new position in AbbVie (ABBV) in Q1 2026: 20,010 shares worth $4.35M. The stake represents 0.02% of the portfolio and ranks #556 among its holdings. This is a return to the name: Hudson Bay Capital Management previously reported a position in ABBV as recently as Q3 2025.
Hudson Bay Capital Management first reported a position in ABBV in Q3 2014 and has held it in 15 quarters since. The position peaked at $136M in Q1 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Hudson Bay Capital Management held 20,010 shares of AbbVie worth $4.35M as of Q1 2026.
- AbbVie was a new Hudson Bay Capital Management position in Q1 2026.
- AbbVie made up 0.02% of Hudson Bay Capital Management's portfolio in Q1 2026, its #556 holding.
- Hudson Bay Capital Management first reported a position in AbbVie in Q3 2014 and has held it in 15 quarters since.
- Hudson Bay Capital Management's AbbVie position peaked at $136M in Q1 2025.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.